Covered recipient · General Payments record
CAROL FOSTER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$3,896.10
- Reported across 189 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $499.64 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $201.44 | 7 |
| SK Life Science, Inc. | $89.75 | 3 |
| PFIZER INC. | $78.14 | 4 |
| Lilly USA, LLC | $44.81 | 2 |
| UCB, Inc. | $41.19 | 1 |
| Lundbeck LLC | $23.91 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.94 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103745013 | CMS |
| ABBVIE INC. | $27.16 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103745015 | CMS |
| ABBVIE INC. | $29.62 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103745017 | CMS |
| ABBVIE INC. | $32.65 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103745019 | CMS |
| ABBVIE INC. | $31.87 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103745021 | CMS |
| ABBVIE INC. | $30.86 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103745023 | CMS |
| ABBVIE INC. | $25.34 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103745025 | CMS |
| Lilly USA, LLC | $26.66 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136087128 | CMS |
| Lilly USA, LLC | $18.15 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136089758 | CMS |
| Lundbeck LLC | $23.91 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145916041 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.40 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118893664 | CMS |
| PFIZER INC. | $18.62 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131558847 | CMS |
| PFIZER INC. | $17.59 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131746168 | CMS |
| PFIZER INC. | $17.78 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131885433 | CMS |
| PFIZER INC. | $24.15 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131084781 | CMS |
| SK Life Science, Inc. | $26.27 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154150579 | CMS |
| SK Life Science, Inc. | $29.45 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154150600 | CMS |
| SK Life Science, Inc. | $34.03 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154150636 | CMS |
| UCB, Inc. | $41.19 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143356509 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.